Assist. Prof. Dr. Yen-Chein Lai | Developmental Neuroscience | Research Excellence Award
Assist. Prof. Dr. Yen-Chein Lai | Chung Shan Medical University | Taiwan
258
24
8
Citations
Documents
h-index
Citations
Documents
h-index
Citations
Documents
h-index
View Scopus Profile View OrcidProfile
Camargo Ortega, G., Falk, S., Johansson, P. A., Peyre, E., Broix, L., Sahu, S. K., … (2019). The centrosome protein AKNA regulates neurogenesis via microtubule organization. Nature, 567(7746), 113–117.
Zaidi, D., Chinnappa, K., & Francis, F. (2022). Primary cilia influence progenitor function during cortical development. Cells, 11(18), 2895.
Chinnappa, K., Cárdenas, A., Prieto-Colomina, A., Villalba, A., … (2022). Secondary loss of miR-3607 reduced cortical progenitor amplification during rodent evolution. Science Advances, 8(2), eabj4010.
Prieto-Colomina, A., Fernández, V., Chinnappa, K., & Borrell, V. (2021). MiRNAs in early brain development and pediatric cancer: At the intersection between healthy and diseased embryonic development. BioEssays, 43(7), 2100073.
Chatterjee, A., Chinnappa, K., Ramanan, N., & Mani, S. (2018). Centrosome inheritance does not regulate cell fate in granule neuron progenitors of the developing cerebellum. The Cerebellum, 17(5), 685–691.
Zaidi, D., Chinnappa, K., Yigit, B. N., Viola, V., Cifuentes-Diaz, C., Jabali, A., … (2024). Forebrain Eml1 depletion reveals early centrosomal dysfunction causing subcortical heterotopia. Journal of Cell Biology, 223(12), e202310157.
Chinnappa, K., Márquez-Galera, Á., Prieto-Colomina, A., Nomura, Y., … (2019). MIR3607 regulates cerebral cortex development via activation of Wnt/βCat signaling. bioRxiv, 729939.
Chinnappa, K., Ballorin, F., & Francis, F. (2025). Fundamental Neurochemistry Review: Sphingolipids and ceramides in brain development. Journal of Neurochemistry, 169(10), e70262.
(2025). Factors influencing source separation intention for improving waste management in educational places: A case study for a university campus. International Journal of Environmental Health Engineering.
(2024). Microplastics contamination in popular soft drinks and non-alcoholic beverages marketed in Iran: Quantity and characteristics. Results in Engineering.
(2024). Soil pollution indices and health risk assessment of metal(loid)s in the agricultural soil of pistachio orchards. Scientific Reports.
(2024). Treatment of real carwash wastewater using high-efficiency and energy-saving electrocoagulation technique. Sustainable Chemistry and Pharmacy.
(2024). Water recovery and treatment of spent filter backwash from drinking water using chemical reactor–ultrafiltration process. Journal of Water Process Engineering.
(2024). Utilization of local corn (Zea mays) wastes for bioethanol production by separate hydrolysis and fermentation. Journal of Hazardous Materials Advances.
Ms. Karen Kikuta is an accomplished MD Candidate at the UCLA David Geffen School of Medicine with expertise in neuroscience, immunology, and global health research. She earned her B.S. in Neuroscience with minors in Public Health and Biology from Santa Clara University and conducted advanced immunological studies at Stanford University’s Binns Program for Cord Blood Research, investigating immune cell subsets using flow cytometry and single-cell RNA sequencing. Her work has resulted in publications in high-impact journals, including Frontiers in Immunology and the International Journal of Infectious Diseases. Karen has contributed to seven major research projects spanning neurodevelopment, infectious disease, and translational medicine, notably pioneering studies on antenatal Zika virus exposure and its long-term neurobehavioral and cardiac outcomes in children. Her research portfolio includes 2 published documents, 45 citations, and an h-index of 2. She has presented findings at national and international conferences, reflecting her dedication to bridging laboratory discoveries with clinical application. As a member of the American Academy of Neurology and the American Neurological Association, Karen is committed to integrating scientific innovation with compassionate care to advance understanding and treatment of neuroinfectious and developmental disorders.
Kikuta, K., Hernandez, C. J., Dunshee de Abranches, A., Damasceno, L., de Britto, J. A., Jardim Duarte, C., Vasconcelos, Z., Zin, A., Brasil, P., Moreira, M. E., & Nielsen-Saines, K. (2025). Academic and social-behavioral assessment in a prospective cohort of normocephalic school-aged children with antenatal Zika virus exposure. International Journal of Infectious Diseases, 159, Article 108026.
Prof. Rosario Osta Pinzolas is a distinguished geneticist and full professor at the University of Zaragoza, Spain. Her academic roots in veterinary sciences and a Ph.D. in Genetics laid the foundation for a prolific career in biomedical research, particularly in the fields of neuroscience and genetic disorders. With leadership roles in multiple high-profile research consortia such as CIBERNED, TRICALS, and ENCALS, she has established herself as a central figure in neurodegenerative disease research. Her scholarly output includes over 100 indexed publications, multiple national and international research projects, and an h-index exceeding 45.
Rosario Osta Pinzolas began her academic journey with a solid foundation in veterinary sciences, graduating as Licenciada en Veterinaria from the University of Zaragoza in 1989. Her academic inclinations quickly shifted toward molecular genetics, leading her to complete a Ph.D. in Genetics at the same university in 1994. Her early studies were driven by a deep curiosity about the mechanisms of heredity and gene expression, setting the tone for a lifelong commitment to biomedical research. These formative years cultivated her scientific rigor and sowed the seeds for a career that would eventually bridge basic science and translational medicine.
Prof. Osta currently holds the esteemed title of Catedrática (Full Professor) in the Department of Anatomy, Embryology, and Genetics at the Faculty of Veterinary Medicine, University of Zaragoza. Since 2018, she has led her department with a focus on integrative biomedical sciences. She is the principal investigator of the LAGENBIO group recognized by both the Aragon Health Research Institute and the Government of Aragon. Under her leadership, the group has developed two major subprograms: TERAGEN and REGENERAGEN. As coordinator of the “Neuroscience and Mental Health Program” at IISA, she has spearheaded numerous efforts to understand and address neurological diseases through genetic approaches.
A prominent figure in neuroscience, Prof. Osta’s research lies at the intersection of genetics and neurodegeneration. She is currently the principal investigator of the only Aragon-based group within CIBERNED (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas), reflecting her national influence. Her team represents Zaragoza in prominent European consortia such as TRICALS and ENCALS, both focused on amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. Through more than 100 indexed publications, predominantly in top-tier journals, her work delves into the molecular underpinnings of neurological disorders and explores regenerative medicine strategies, thereby contributing to innovative therapeutic avenues.
Prof. Osta’s academic and research career has been punctuated by consistent recognition. She has completed five research productivity periods and one technology transfer period, acknowledged by CNEAI — a mark of sustained scientific impact. She has led over 74 research projects and contributed to more than 100 collaboration contracts, earning her four competitive research awards from respected institutions including CORIS, AREA, IIS, and SEBBM. Her contributions have been lauded not only for scientific quality but also for practical relevance in biomedical advancements.
An ardent advocate for science with societal impact, Prof. Osta has significantly contributed to technology transfer. She holds nine patents, five of which have been licensed to industry partners. Her collaborations with companies have led to meaningful translational outputs, emphasizing her role in bridging the gap between academic research and real-world solutions. As former Director of the Technology Transfer and Innovation Secretariat at the University of Zaragoza for nearly a decade, she played a crucial role in institutional innovation strategies. Her involvement in joint university-company chairs and her role in the UZ Technology-Based Business Creation Committee for over 12 years further underscore her influence on academic entrepreneurship.
Beyond the lab, Prof. Osta has left a profound mark as an educator and mentor. Since 2013, she has coordinated the Interuniversity Doctoral Program in Biomedical and Biotechnological Sciences, a joint initiative between the Universities of Zaragoza and La Rioja. Her mentorship includes the supervision of 13 Ph.D. theses — 9 of which earned international distinction and 6 received extraordinary doctoral awards. Her influence extends to guiding numerous undergraduate and master’s theses, fostering a new generation of scientists with a deep commitment to research excellence and innovation.
Prof. Rosario Osta’s legacy is defined by her ability to integrate scientific discovery, mentorship, and innovation. As a member of the Scientific Committee of the Luzón Foundation, her vision reaches beyond academia into public health advocacy and strategic research planning. With nearly 19,000 citations on Google Scholar and an h-index of 45, her work continues to inspire and inform global research communities. Her continued leadership in collaborative European projects ensures her contributions will shape the future of neuroscience, genetics, and translational medicine for years to come.
Title: Novel FKBP prolyl isomerase 1A (FKBP12) ligand promotes functional improvement in SOD1G93A amyotrophic lateral sclerosis (ALS) mice
Authors: L. Moreno-Martinez, N. Gaja-Capdevila, L. Mosqueira-Martín, R. Osta, F.J. Gil-Bea
Year: 2025
Title: Identifying Hub Genes and miRNAs Associated with Alzheimer’s Disease: A Bioinformatics Pathway to Novel Therapeutic Strategies
Authors: E. Gascón, A.C. Calvo, N. Molina, P. Zaragoza, R. Osta
Year: 2024
Title: Comparative Blood Profiling Based on ATR-FTIR Spectroscopy and Chemometrics for Differential Diagnosis of Patients with Amyotrophic Lateral Sclerosis—Pilot Study
Authors: K. Tkachenko, J.M. González Sáiz, A.C. Calvo, R. Osta, C. Pizarro Millán
Year: 2024
Title: Sex differences on constitutive long non-coding RNA expression: Modulatory effect of estradiol and testosterone in muscle cells
Authors: T. López-Royo, L. Moreno-Martinez, L. Moreno-García, R. Manzano, R. Osta
Year: 2024
Title: Differentially expressed lncRNAs in SOD1 G93A mice skeletal muscle: H19, Myhas and Neat1 as potential biomarkers in amyotrophic lateral sclerosis
Authors: T. López-Royo, L. Moreno-Martinez, P. Zaragoza, R. Manzano, R. Osta
Year: 2024
Title: Proteomic profiling of human plasma extracellular vesicles identifies PF4 and C1R as novel biomarker in sarcopenia
Authors: P. Aparicio, D. Navarrete-Villanueva, A. Gómez-Cabello, R. Osta, R. Manzano
Year: 2024
Title: Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes
Authors: E. Gascón, P. Zaragoza, A.C. Calvo, R. Osta
Year: 2024
Title: Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population
Authors: D. Borrego-Hernández, J.F. Vázquez-Costa, R. Domínguez Rubio, M. Povedano, A. García-Redondo
Year: 2024
Title: New Insights into Endogenous Retrovirus-K Transcripts in Amyotrophic Lateral Sclerosis
Authors: L. Moreno-Martinez, S. Macías-Redondo, M.H.P. Strunk, R. Osta, J. Schoorlemmer
Year: 2024
Title: Analysis of Plasma-Derived Exosomal MicroRNAs as Potential Biomarkers for Canine Idiopathic Epilepsy
Authors: M. García-Gracia, L. Moreno-Martinez, A. Hernaiz, S. García-Belenguer, I. Martín-Burriel
Year: 2024
Based on her outstanding research contributions, innovation in translational science, mentorship record, and leadership within national and European research programs, Prof. Rosario Osta Pinzolas is an exceptionally strong candidate for the Best Researcher Award. Her profile reflects not only academic excellence but also societal impact and visionary leadership. While there is room for enhanced global outreach, her sustained achievements and contributions make her highly deserving of this prestigious recognition.
Assoc. Prof. Silviya Ivanova Filkova is a distinguished academic and practitioner in the field of rehabilitation and public health. With a foundational degree in rehabilitation from Sofia and two Master’s degrees in Health Management and Wellness & SPA Therapy from Varna, she has continuously advanced her academic and professional qualifications. Since 2012, she has been a pivotal educator at the Medical University – Varna, teaching therapeutic massage and kinesitherapy. Her doctoral research focused on spinal deformity prevention in preschool children, aligning with her broader research interest in scoliosis, functional deformities, and health promotion. She has undergone specialized international training, contributed over 100 scholarly publications, and authored a monograph on spinal health in the modern lifestyle. Her academic work is matched by a strong presence in national and international scientific forums.
Assoc. Prof. Silviya Ivanova Filkova began her journey into the field of rehabilitation with a solid educational foundation. She graduated in 1992 with a degree in “Rehabilitator” from the esteemed Medical College “Y. Filaretova” in Sofia, Bulgaria. Her thirst for knowledge and dedication to professional development led her to pursue advanced degrees, earning a Master’s in “Health Management” in 2000 and a second Master’s in “Rehabilitation, Balneotherapy, Wellness, and SPA” in 2016, both from the Medical University “Prof. Dr. Paraskev Stoyanov” – Varna. These academic achievements marked the beginning of her lifelong commitment to advancing the fields of rehabilitation and public health.
Silviya Filkova began her professional career as a rehabilitator immediately after graduation in 1992, laying a strong foundation through hands-on clinical practice. Her transition into academia came in 2012 when she joined the “Rehabilitator” Department at the Medical College of the Medical University – Varna as an Assistant Professor. Since then, she has been instrumental in educating and mentoring students in therapeutic massage and kinesitherapy. Her dual engagement in both clinical and academic domains has made her a respected figure in rehabilitation sciences.
A defining moment in her academic career came in 2017 when she earned her PhD in “Public Health Management” after successfully defending her dissertation on “Prevention of Spinal Deformities in Preschool Children.” This study underscored her dedication to pediatric spinal health and laid the groundwork for her future research. She has continually expanded her expertise through specialized training in globally recognized scoliosis therapy methods, including SEAS (Scientific Exercises Approach to Scoliosis), Schroth BSPTS, and FITS (Functional Individual Therapy of Scoliosis). Her core research interests lie in spinal deformities, physical activity, and health promotion.
Assoc. Prof. Filkova’s dedication to her field is reflected in her prolific academic output and continued specialization. In 2023, she was awarded a specialty in “Public Health,” complementing her broader focus on healthcare improvement and prevention strategies. Her completion of international certifications under renowned instructors like Michele Romano and Dr. Manuel Rigo attests to her commitment to maintaining high professional standards. Her contributions have been recognized not only through academic promotions but also by the high regard in which she is held by her peers and students.
Her influence extends beyond the classroom and clinic through her active participation in scientific events, both nationally and internationally. With over 100 publications in Bulgarian and international scientific journals, Assoc. Prof. Filkova has contributed substantially to the literature on health and rehabilitation. Her work has enhanced understanding of modern lifestyle impacts on spinal health and shaped approaches to non-invasive treatments for scoliosis and other musculoskeletal disorders. She also authored a monograph titled “Modern Lifestyle and Functional Spinal Deformities”, which adds value to the academic and clinical discussions in this field.
Assoc. Prof. Filkova has become a prominent figure in fostering interdisciplinary approaches in rehabilitative health sciences. Her consistent involvement in continuing education, scholarly activities, and development of therapeutic techniques ensures that her legacy will include both scientific innovation and the nurturing of future professionals. Her work bridges traditional rehabilitation with modern methodologies, integrating scientific research into practical healthcare.
Title: Assessing the impact of prolonged sitting and poor posture on lower back pain: A photogrammetric and machine learning approach
Author(s): V. Markova, M. Markov, Z. Petrova, S. Filkova
Year: 2024
Title: Necessity for becoming aware of the physical activity as a model of health behaviour
Author(s): V.K. Silviya Filkova, Vanya Todorova
Year: 2013
Title: Ролята на ранната профилактика в управлението на остеопорозата
Author(s): М. Михайлова, С. Филкова
Year: 2017
Title: The effect of polarized polychromatic non-coherent light (Bioptron) therapy on patients with lower back pain
Author(s): M. Mihaylova, Z. Ruseva, S. Filkova
Year: 2017
Title: Raising the parents’ awareness of the importance of the physical activity for the children health
Author(s): S.F. Tаrpomanova Tsv.
Year: 2016
Title: Проучване на двигателната активност на деца със затлъстяване
Author(s): С. Филкова, С. Богомилова, Ц. Търпоманова
Year: 2015
Title: Физическа активност при възрастните хора с остеопороза
Author(s): К. Моллова, М. Алберт, С. Филкова, Р. Джуркова
Year: 2017
Title: Сравнително изследване на мотивацията за избор на специалност на студенти от I-ви курс от специалностите „Рехабилитатор” и „Инспектор по обществено здраве”
Author(s): Ц. Търпоманова, С. Филкова
Year: 2014
Assoc. Prof. Filkova’s career is a testament to the integration of clinical expertise, academic excellence, and continuous professional growth. Her impactful research on spinal deformities and preventive rehabilitation, coupled with her dedication to education and public health, has significantly shaped the rehabilitative sciences in Bulgaria and beyond. As she continues to innovate and inspire through research and teaching, her work promises lasting contributions to public health, especially in the areas of pediatric rehabilitation and health promotion. Her legacy lies not only in scientific advancement but also in the countless students and patients she has guided throughout her remarkable career.
Takeshi Sakurai, M.D., Ph.D., is a distinguished academic whose career spans across key positions in neuroscience, pharmacology, and integrative sleep medicine. After earning his M.D. and Ph.D. from the University of Tsukuba, he embarked on a journey of groundbreaking research, primarily focusing on neurotransmission and sleep regulation. Sakurai’s postdoctoral work in prestigious institutions, coupled with his leadership of major projects like the Yanagisawa Orphan Receptor Project, established him as a leader in molecular neuroscience. Over the years, he has earned recognition through accolades and significant academic positions, including his current role as Professor and Vice Director at the University of Tsukuba’s International Institute for Integrative Sleep Medicine. His research continues to shape the understanding of sleep and brain function, while his influence extends to mentoring the next generation of scientists.
Takeshi Sakurai’s academic journey began with his medical studies at the University of Tsukuba, where he earned his M.D. in 1989. During his early years at the university, he developed a keen interest in the molecular mechanisms of biological systems. This curiosity led him to pursue a Ph.D. in medicine, which he completed in 1993. His doctoral research focused on the cloning of a cDNA encoding a non-isopetide-selective subtype of the endothelin receptor, a project that was published in Nature in 1990, marking the beginning of his significant contributions to molecular pharmacology.
Following his Ph.D., Sakurai embarked on a promising career in academic research, starting as a postdoctoral fellow at the Institute of Basic Medical Sciences in 1993. His career rapidly advanced as he took on various roles, including Assistant Professor at the same institute. During his tenure, he also worked as a postdoctoral fellow at the prestigious Howard Hughes Medical Institute at the University of Texas Southwestern Medical Center in Dallas from 1995 to 1996. These experiences broadened his expertise in pharmacology and molecular neuroscience, laying the foundation for his future academic leadership roles. By 1999, he became an Associate Professor at the University of Tsukuba and contributed significantly to the university’s research landscape.
Sakurai’s research is primarily centered around molecular neuroscience, pharmacology, and integrative physiology. His work has been pivotal in advancing the understanding of biological systems and their regulation at the molecular level. Notably, his leadership of the Yanagisawa Orphan Receptor Project under the Exploratory Research for Advanced Technology (ERATO) of the Japan Science and Technology Corporation highlights his role in pioneering research on orphan receptors. His continued focus on the mechanisms of neurotransmission and their involvement in sleep regulation has earned him a place as a leading researcher in the field of integrative sleep medicine.
Throughout his career, Sakurai has earned widespread recognition for his contributions to medicine and neuroscience. His groundbreaking work on neurotransmitter systems and sleep regulation has led to his appointment as a Professor and Vice Director at the University of Tsukuba’s International Institute for Integrative Sleep Medicine. His research has not only shaped the scientific community’s understanding of brain function but also garnered him numerous accolades, further cementing his reputation as a thought leader in the field.
Sakurai’s impact extends far beyond his own research. As a professor, he has mentored countless students and researchers who have gone on to make their own significant contributions in the fields of neuroscience and pharmacology. His interdisciplinary approach to sleep medicine has influenced research on neurodegenerative diseases, mental health, and drug development. The work he has pioneered in molecular neuroscience has also paved the way for advances in treatment approaches for disorders related to sleep and neurotransmission, offering hope for improved therapeutic interventions.
Looking ahead, Sakurai’s legacy in neuroscience and integrative sleep medicine is poised to continue influencing both academic research and clinical practice. His innovative research on sleep regulation and the molecular mechanisms underpinning brain function will undoubtedly remain foundational in the future of both basic and applied medical sciences. As he continues his work at the University of Tsukuba, Sakurai’s future contributions will likely expand our understanding of the brain’s intricate systems and their broader implications for human health. His career exemplifies a dedication to advancing science, and his ongoing research promises to address critical challenges in medicine and health.
In addition to his personal research achievements, Sakurai’s role in academic leadership cannot be understated. As a professor at the University of Tsukuba, he has played a pivotal role in shaping the institution’s research direction and academic programs, particularly within the fields of integrative physiology and sleep medicine. His influence extends through the mentorship of students, guiding the next generation of researchers who will continue to build on his work. Sakurai’s commitment to education and his support for innovative research initiatives are key to his lasting impact on the academic and medical communities.
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
Authors: T Sakurai, A Amemiya, M Ishii, I Matsuzaki, RM Chemelli, H Tanaka, …
Year: 1998
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
Authors: T Sakurai, M Yanagisawa, Y Takuwat, H Miyazakit, S Kimura, K Goto, …
Year: 1990
Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity
Authors: J Hara, CT Beuckmann, T Nambu, JT Willie, RM Chemelli, CM Sinton, …
Year: 2001
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
Authors: JT Glessner, K Wang, G Cai, O Korvatska, CE Kim, S Wood, H Zhang, …
Year: 2009
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
Author: T Sakurai
Year: 2007
Distribution of orexin neurons in the adult rat brain
Authors: T Nambu, T Sakurai, K Mizukami, Y Hosoya, M Yanagisawa, K Goto
Year: 1999
Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems
Authors: Y Date, Y Ueta, H Yamashita, H Yamaguchi, S Matsukura, K Kangawa, …
Year: 1999
Hypothalamic orexin neurons regulate arousal according to energy balance in mice
Authors: A Yamanaka, CT Beuckmann, JT Willie, J Hara, N Tsujino, M Mieda, …
Year: 2003
Plastic stress-strain matrix and its application for the solution of elastic-plastic problems by the finite element method
Authors: Y Yamada, N Yoshimura, T Sakurai
Year: 1968
Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area
Authors: CF Elias, CB Saper, E Maratos‐Flier, NA Tritos, C Lee, J Kelly, JB Tatro, …
Year: 1998
Takeshi Sakurai’s work has profoundly impacted the fields of neuroscience, pharmacology, and sleep medicine. His contributions have not only advanced scientific understanding but have also paved the way for practical applications in medical therapies. Through his leadership and mentorship, Sakurai’s legacy is set to endure, with his future research promising further advancements in understanding the complexities of the brain and its regulation. His dedication to advancing both science and education ensures that his influence will continue to resonate in academic and clinical circles for years to come.
Dr. Jin Yong Hong, MD, PhD, is a distinguished neurologist and academic leader with a career grounded in excellence, innovation, and service. Beginning his medical education at Yonsei University, he steadily advanced through rigorous academic and clinical pathways to become an Associate Professor at Yonsei University Wonju College of Medicine. His focused expertise in movement disorders and dementia, enriched by both national and international research experience, especially at the University of Pennsylvania, highlights his dedication to solving complex neurological diseases. Through teaching, research, and clinical practice, he has significantly contributed to the growth of neuroscience and medical education in South Korea.
Dr. Jin Yong Hong embarked on his journey in medicine with a deep commitment to academic excellence, beginning with his premedical studies at Yonsei University in Seoul from 2001 to 2003. He swiftly advanced through the rigorous medical curriculum, earning a Bachelor of Medical Science in 2007. Not content with just clinical practice, he pursued higher education with a Master of Medical Science completed in 2014 and culminated his scholarly journey with a Doctorate in Medical Science from the same esteemed institution in 2021. His academic path reflects a relentless pursuit of knowledge in the neurological sciences and a strong foundation in research methodology and clinical application.
Following his graduation, Dr. Hong immersed himself in hands-on clinical training, beginning with an internship and residency in Neurology at the renowned Severance Hospital of the Yonsei University Health System. This period, from 2007 to 2012, was marked by rigorous clinical immersion and specialization. His passion for neuroscience led him to pursue subspecialty training in Movement Disorders and Dementia, completing both clinical and research fellowships. Notably, he expanded his research exposure internationally through a postdoctoral fellowship at the University of Pennsylvania in the United States from 2022 to 2024, further enriching his expertise in neurodegenerative pathology and laboratory medicine.
Dr. Hong’s research has consistently revolved around movement disorders and dementia, placing him at the forefront of understanding neurodegenerative diseases. His clinical experience, paired with extensive research work in both Korea and the United States, underscores his commitment to unraveling the complexities of disorders like Parkinson’s disease, Alzheimer’s disease, and related cognitive impairments. His interdisciplinary approach bridges clinical neurology with translational science, contributing significantly to advancing diagnostic and therapeutic strategies in the field.
As an Associate Professor at the Department of Neurology, Yonsei University Wonju College of Medicine, Dr. Hong plays a vital role in shaping the next generation of neurologists. Since 2016, he has not only led clinical initiatives but also mentored students and junior faculty. His previous tenure as a Clinical Assistant Professor from 2014 to 2016 helped lay the groundwork for a collaborative and research-driven academic environment at the Wonju Severance Christian Hospital. His academic roles have helped blend clinical excellence with cutting-edge research in one of Korea’s premier medical institutions.
Dr. Hong’s excellence has been consistently recognized by peers and institutions alike. In 2014, he received the Academic Award for Highest Achievement from Yonsei University College of Medicine, marking him as a top-tier scholar among his peers. The same year, he was awarded a Fellowship by the Korean Movement Disorder Society, acknowledging his promising contributions to the field. Further cementing his role as a leading voice in neurological research, he was honored in 2021 with the JMD Article Award, reflecting the impact and relevance of his scholarly publications.
With active memberships in the Korean Neurological Association, the Korean Movement Disorder Society, and the Korean Dementia Association, Dr. Hong maintains an influential presence within the scientific community. His cross-continental experience, especially through his postdoctoral work in the United States, has positioned him as a bridge between Eastern and Western neurological research paradigms. His publications and ongoing collaborations continue to influence both clinical practice and academic discourse, especially in the diagnosis and management of neurodegenerative conditions.
Looking ahead, Dr. Jin Yong Hong is poised to continue making groundbreaking contributions in the field of neurology. With a career marked by academic distinction, clinical expertise, and research innovation, he represents a model of holistic excellence in medicine. His future work is likely to delve deeper into translational neuroscience, aiming to develop practical solutions for patients suffering from movement and cognitive disorders. As a mentor, researcher, and clinician, Dr. Hong is building a legacy that will inspire and influence the medical community for years to come.
Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson’s disease
S Shin, JE Lee, JY Hong, MK Sunwoo, YH Sohn, PH Lee
2012
Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease
JY Hong, JS Oh, I Lee, MK Sunwoo, JH Ham, JE Lee, YH Sohn, JS Kim, …
2014
The MMSE and MoCA for screening cognitive impairment in less educated patients with Parkinson’s disease
JI Kim, MK Sunwoo, YH Sohn, PH Lee, JY Hong
2016
The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson’s disease
MK Sunwoo, S Jeon, JH Ham, JY Hong, JE Lee, JM Lee, YH Sohn, …
2014
Cerebral microbleeds in patients with Parkinson’s disease
JH Ham, H Yi, MK Sunwoo, JY Hong, YH Sohn, PH Lee
2014
Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson’s disease
JY Hong, MK Sunwoo, SJ Chung, JH Ham, JE Lee, YH Sohn, PH Lee
2014
Clinical and biomarker characteristics according to clinical spectrum of Alzheimer’s disease (AD) in the validation cohort of Korean Brain Aging Study for the Early Diagnosis …
J Hwang, JH Jeong, SJ Yoon, KW Park, EJ Kim, B Yoon, JW Jang, HJ Kim, …
2019
Subjective cognitive complaints and objective cognitive impairment in Parkinson’s disease
JY Hong, Y Lee, MK Sunwoo, YH Sohn, PH Lee
2018
Neurocognitive and atrophic patterns in Parkinson’s disease based on subjective memory complaints
JY Hong, JE Lee, YH Sohn, PH Lee
2012
Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer’s disease
SH Koh, SH Choi, JH Jeong, JW Jang, KW Park, EJ Kim, HJ Kim, JY Hong, …
2020
Dr. Hong’s journey illustrates the profound impact one dedicated individual can make within the scientific and medical communities. His legacy is already evident in his scholarly achievements, the students he mentors, and the patients he serves. As he continues to advance the understanding and treatment of neurological conditions, Dr. Hong remains a beacon of academic integrity, scientific rigor, and compassionate care. His future promises continued breakthroughs that will shape the field of neurology and bring hope to countless lives affected by neurodegenerative disorders.